| 小细胞肺癌药物治疗新进展 |
| |
| 引用本文： | 申红丽.小细胞肺癌药物治疗新进展[J].医学综述,2011,17(4):536-539. |
| |
| 作者姓名： | 申红丽 |
| |
| 作者单位： | 新疆医科大学附属肿瘤医院内一科,乌鲁木齐,830011 |
| |
| 摘 要： | 小细胞肺癌(SCLC)是恶性程度很高的肿瘤,其治疗也是肺癌治疗领域中的难点,因而SCLC长期生存率很低。近年来更多新药物、新方案分别用于SCLC一线化疗、二线化疗及分子靶向治疗的各期临床研究,尽管很多仍有待于深入研究和探索,但其治疗研究将为SCLC进一步联合化疗提供更多新的治疗策略和选择方案,由此提高患者生存率。
|
| 关 键 词： | 小细胞肺癌 一线化疗 二线化疗 分子靶向治疗 |
New Progress of Small Cell Lung Cancer Medical Treatment |
| |
| SHEN Hong-li.New Progress of Small Cell Lung Cancer Medical Treatment[J].Medical Recapitulate,2011,17(4):536-539. |
| |
| Authors: | SHEN Hong-li |
| |
| Institution: | SHEN Hong-li,SHAN Li.(First Department of Imternal Medicine,Tumor Hospital Affiliated to Xinjiang Medical University,Urumqi 830011,China) |
| |
| Abstract: | Small cell lung cancer（SCLC）is a highly malignant tumor,and it′s treatment is difficult in the field of lung cancer,so long-term survival of SCLC is very low.In recent years,more new drugs,new methods are used as the first-line chemotherapy for SCLC,the second-line chemotherapy and molecular targeted therapy in all clinical research stages.Although many points need to be in-depth studied and explored the treatment research of SCLC will provide more new chemotherapy treatment strategies and options,which may improve patient′s survival rate. |
| |
| Keywords: | Small cell lung cancer The first-line chemotherapy The second-line chemotherapy Molecular target therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
